Microglia as therapeutic targets after neurological injury: strategy for cell therapy

References

• Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18(4):225–242.
   PubMed Web of Science ®Google Scholar
• Cox CS Jr. Cellular therapy for traumatic neurological injury. Pediatr Res. 2018;83(1–2):325–332.
   PubMed Web of Science ®Google Scholar
• Loane DJ, Kumar A, Stoica BA, et al. Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation. J Neuropathol Exp Neurol. 2014;73(1):14–29.
   PubMed Web of Science ®Google Scholar
• Ramlackhansingh AF, Brooks DJ, Greenwood RJ, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011;70(3):374–383.
   PubMed Web of Science ®Google Scholar
• Prossin AJ,J, Savitz S, Zubieta JK, et al. Preliminary in vivo evidence of neuroimmune activation in chronic pain states in humans: analgesic reversal with autologous stem cell treatment. Proc Am Coll Neuropsychopharmacology. 2018;57:T254.
   Google Scholar
• Raghavendra Rao VL, Dogan A, Bowen KK, et al. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp Neurol. 2000;161(1):102–114.
   PubMed Web of Science ®Google Scholar
• Rotshenker S. Wallerian degeneration: the innate-immune response to traumatic nerve injury. J Neuroinflammation. 2011;8:109.
   PubMed Web of Science ®Google Scholar
• Aertker BM, Kumar A, Prabhakara KS, et al. Pre-injury monocyte/macrophage depletion results in increased blood-brain barrier permeability after traumatic brain injury. J Neurosci Res. 2019;97(6):698–707.
   PubMed Web of Science ®Google Scholar
• Pannell M, Economopoulos V, Wilson TC, et al. Imaging of translocator protein upregulation is selective for pro-inflammatory polarized astrocytes and microglia. Glia. 2020;68(2):280–297.
   PubMed Web of Science ®Google Scholar
• Robinson AP, White TM, Mason DW. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology. 1986;57(2):239–247.
   PubMed Web of Science ®Google Scholar
• Ito D, Imai Y, Ohsawa K, et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998;57(1):1–9.
   PubMedGoogle Scholar
• Prinz M, Tay TL, Wolf Y, et al. Microglia: unique and common features with other tissue macrophages. Acta Neuropathol. 2014;128(3):319–331.
   PubMed Web of Science ®Google Scholar
• Jung S, Aliberti J, Graemmel P, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol. 2000;20(11):4106–4114.
   PubMed Web of Science ®Google Scholar
• Boillee S, Yamanaka K, Lobsiger CS, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312(5778):1389–1392.
   PubMed Web of Science ®Google Scholar
• Goldmann T, Wieghofer P, Jordao MJ, et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat Immunol. 2016;17(7):797–805.
   PubMed Web of Science ®Google Scholar
• Wieghofer P, Knobeloch KP, Prinz M. Genetic targeting of microglia. Glia. 2015;63(1):1–22.
   PubMed Web of Science ®Google Scholar
• Bennett ML, Bennett FC, Liddelow SA, et al. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. 2016;113(12):E1738–46.
   PubMed Web of Science ®Google Scholar
• Mildner A, Huang H, Radke J, et al. P2Y12 receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseases. Glia. 2017;65(2):375–387.
   PubMed Web of Science ®Google Scholar
• Amadio S, Parisi C, Montilli C, et al. P2Y(12) receptor on the verge of a neuroinflammatory breakdown. Mediators Inflamm. 2014;2014:975849.
   PubMed Web of Science ®Google Scholar
• Mildner A. Ghosts in the shell: identification of microglia in the human central nervous system by P2Y12 receptor. Neural Regen Res. 2017;12(4):570–571.
   PubMed Web of Science ®Google Scholar
• Bedard A, Tremblay P, Chernomoretz A, et al. Identification of genes preferentially expressed by microglia and upregulated during cuprizone-induced inflammation. Glia. 2007;55(8):777–789.
   PubMed Web of Science ®Google Scholar
• Gautier EL, Shay T, Miller J, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol. 2012;13(11):1118–1128.
   PubMed Web of Science ®Google Scholar
• Butovsky O, Jedrychowski MP, Moore CS, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17(1):131–143.
   PubMed Web of Science ®Google Scholar
• Chiu IM, Morimoto ET, Goodarzi H, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4(2):385–401.
   PubMed Web of Science ®Google Scholar
• Konishi H, Kobayashi M, Kunisawa T, et al. Siglec-H is a microglia-specific marker that discriminates microglia from CNS-associated macrophages and CNS-infiltrating monocytes. Glia. 2017;65(12):1927–1943.
   PubMed Web of Science ®Google Scholar
• Esaulova E, Cantoni C, Shchukina I, et al. Single-cell RNA-seq analysis of human CSF microglia and myeloid cells in neuroinflammation. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):1-11.
   Web of Science ®Google Scholar
• Hammond TR, Dufort C, Dissing-Olesen L, et al. Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity. 2019;50(1):253–271. e6.
   PubMed Web of Science ®Google Scholar
• Li Q, Cheng Z, Zhou L, et al. Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron. 2019;101(2):207–223. e10.
   PubMed Web of Science ®Google Scholar
• Sousa C, Golebiewska A, Poovathingal SK, et al. Single-cell transcriptomics reveals distinct inflammation-induced microglia signatures. EMBO Rep. 2018;19(11):e46171.
   Web of Science ®Google Scholar
• Toledano Furman N, Gottlieb A, Prabhakara KS, et al. High-resolution and differential analysis of rat microglial markers in traumatic brain injury: conventional flow cytometric and bioinformatics analysis. Sci Rep. 2020;10(1):11991.
   PubMed Web of Science ®Google Scholar
• Toledano Furman NE, Prabhakara KS, Bedi S, et al. OMIP-041: optimized multicolor immunofluorescence panel rat microglial staining protocol. Cytometry A. 2018;93(2):182–185.
   PubMedGoogle Scholar
• Sankowski R, Bottcher C, Masuda T, et al. Mapping microglia states in the human brain through the integration of high-dimensional techniques. Nat Neurosci. 2019;22(12):2098–2110.
   PubMed Web of Science ®Google Scholar
• Dukhinova M, Kopeikina E, Ponomarev ED. Usage of Multiparameter Flow Cytometry to Study Microglia and Macrophage Heterogeneity in the Central Nervous System During Neuroinflammation and Neurodegeneration. Methods Mol Biol. 2018;1745:167–177.
   PubMedGoogle Scholar
• Amir El AD, Davis KL, Tadmor MD, et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol. 2013;31(6):545–552.
   PubMed Web of Science ®Google Scholar
• Becht E, McInnes L, Healy J, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2019;37:38-44.
   Web of Science ®Google Scholar
• Caplan HW, Prabhakara KS, Kumar A, et al. Human cord blood-derived regulatory T-cell therapy modulates the central and peripheral immune response after traumatic brain injury. Stem Cells Transl Med. 2020;9(8):903–916.
   PubMed Web of Science ®Google Scholar
• Gautreau G, Pejoski D, Le Grand R, et al. SPADEVizR: an R package for visualization, analysis and integration of SPADE results. Bioinformatics. 2017;33(5):779–781.
   PubMed Web of Science ®Google Scholar
• Van Gassen S, Callebaut B, Van Helden MJ, et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A. 2015;87(7):636–645.
   PubMedGoogle Scholar
• Weber LM, Robinson MD. Comparison of clustering methods for high-dimensional single-cell flow and mass cytometry data. Cytometry A. 2016;89(12):1084–1096.
   PubMedGoogle Scholar
• Finak G, Langweiler M, Jaimes M, et al. Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium. Sci Rep. 2016;6:20686.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gomez JA, Kavanagh E, Engskog-Vlachos P, et al. Microglia: agents of the CNS Pro-Inflammatory Response. Cells. 2020;9(7):1717. Doi 10.3390/cells9071717.
   Web of Science ®Google Scholar
• Smith JA, Das A, Ray SK, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87(1):10–20.
   PubMed Web of Science ®Google Scholar
• Yan X, Li F, Maixner DW, et al. Interleukin-1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel-associated acute pain syndrome. Glia. 2019;67(3):482–497.
   PubMed Web of Science ®Google Scholar
• Burguillos MA, Svensson M, Schulte T, et al. Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. Cell Rep. 2015;10(9):1626–1638.
   PubMed Web of Science ®Google Scholar
• Chio CC, Chang CH, Wang CC, et al. Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-alpha. BMC Neurosci. 2013;14:33.
   PubMed Web of Science ®Google Scholar
• Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8(9):1254–1266.
   PubMed Web of Science ®Google Scholar
• Merighi S, Bencivenni S, Vincenzi F, et al. A2B adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway. Pharmacol Res. 2017;117:9–19.
   PubMed Web of Science ®Google Scholar
• Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155(7):1596–1609.
   PubMed Web of Science ®Google Scholar
• Wang J, Ma MW, Dhandapani KM, et al. Regulatory role of NADPH oxidase 2 in the polarization dynamics and neurotoxicity of microglia/macrophages after traumatic brain injury. Free Radic Biol Med. 2017;113:119–131.
   PubMed Web of Science ®Google Scholar
• Zhang QG, Laird MD, Han D, et al. Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury. PLoS One. 2012;7(4):e34504.
   PubMed Web of Science ®Google Scholar
• Dohi K, Ohtaki H, Nakamachi T, et al. Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury. J Neuroinflammation. 2010;7:41.
   PubMed Web of Science ®Google Scholar
• Neher JJ, Neniskyte U, Zhao JW, et al. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J Immunol. 2011;186(8):4973–4983.
   PubMed Web of Science ®Google Scholar
• Mondola P, Damiano S, Sasso A, et al. The Cu, Zn Superoxide Dismutase: not Only a Dismutase Enzyme. Front Physiol. 2016;7:594.
   PubMed Web of Science ®Google Scholar
• Xiao Q, Zhao W, Beers DR, et al. Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. J Neurochem. 2007;102(6):2008–2019.
   PubMed Web of Science ®Google Scholar
• Liao B, Zhao W, Beers DR, et al. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol. 2012;237(1):147–152.
   PubMed Web of Science ®Google Scholar
• Kettenmann H, Hanisch UK, Noda M, et al. Physiology of microglia. Physiol Rev. 2011;91(2):461–553.
   PubMed Web of Science ®Google Scholar
• Capani F, Ellisman MH, Martone ME. Filamentous actin is concentrated in specific subpopulations of neuronal and glial structures in rat central nervous system. Brain Res. 2001;923(1–2):1–11.
   PubMed Web of Science ®Google Scholar
• Madry C, Attwell D. Receptors, ion channels, and signaling mechanisms underlying microglial dynamics. J Biol Chem. 2015;290(20):12443–12450.
   PubMed Web of Science ®Google Scholar
• Yu T, Zhang X, Shi H, et al. P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina II neurons during neuropathic pain in rodents. Cell Death Dis. 2019;10(3):165.
   PubMed Web of Science ®Google Scholar
• Haynes SE, Hollopeter G, Yang G, et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci. 2006;9(12):1512–1519.
   PubMed Web of Science ®Google Scholar
• Rodriguez JJ, Witton J, Olabarria M, et al. Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer’s disease. Cell Death Dis. 2010;1:e1.
   PubMed Web of Science ®Google Scholar
• Fu R, Shen Q, Xu P, et al. Phagocytosis of microglia in the central nervous system diseases. Mol Neurobiol. 2014;49(3):1422–1434.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 2005;201(4):647–657.
   PubMed Web of Science ®Google Scholar
• Rotshenker S, Reichert F, Gitik M, et al. Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia. Glia. 2008;56(15):1607–1613.
   PubMed Web of Science ®Google Scholar
• Neumann J, Sauerzweig S, Ronicke R, et al. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J Neurosci. 2008;28(23):5965–5975.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Castillo E, Frias ES, et al. Bioenergetic regulation of microglia. Glia. 2018;66(6):1200–1212.
   PubMed Web of Science ®Google Scholar
• Harry GJ, Childers G, Giridharan S, et al. An association between mitochondria and microglia effector function. What do we think we know? 2020;7:150–165. Neuroimmunol Neuroinflamm.
   Google Scholar
• Nagy AM, Fekete R, Horvath G, et al. Versatility of microglial bioenergetic machinery under starving conditions. Biochim Biophys Acta Bioenerg. 2018;1859(3):201–214.
   PubMed Web of Science ®Google Scholar
• Devanney NA, Stewart AN, Gensel JC. Microglia and macrophage metabolism in CNS injury and disease: the role of immunometabolism in neurodegeneration and neurotrauma. Exp Neurol. 2020;329:113310.
   PubMed Web of Science ®Google Scholar
• Gimeno-Bayon J, Lopez-Lopez A, Rodriguez MJ, et al. Glucose pathways adaptation supports acquisition of activated microglia phenotype. J Neurosci Res. 2014;92(6):723–731.
   PubMed Web of Science ®Google Scholar
• Holland R, McIntosh AL, Finucane OM, et al. Inflammatory microglia are glycolytic and iron retentive and typify the microglia in APP/PS1 mice. Brain Behav Immun. 2018;68:183–196.
   PubMed Web of Science ®Google Scholar
• Wang L, Pavlou S, Du X, et al. Glucose transporter 1 critically controls microglial activation through facilitating glycolysis. Mol Neurodegener. 2019;14(1):2.
   PubMedGoogle Scholar
• Fodelianaki G, Lansing F, Bhattarai P, et al. Nerve Growth Factor modulates LPS - induced microglial glycolysis and inflammatory responses. Exp Cell Res. 2019;377(1–2):10–16.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhao Y, Sun M, et al. 2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro. Toxicol In Vitro. 2014;28(7):1183–1189.
   PubMed Web of Science ®Google Scholar
• Tu D, Gao Y, Yang R, et al. The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration. J Neuroinflammation. 2019;16(1):255.
   PubMed Web of Science ®Google Scholar
• Dupont AC, Largeau B, Santiago Ribeiro MJ, et al. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases. Int J Mol Sci. 2017;18:4.
   Web of Science ®Google Scholar
• Bonsack F, Sukumari-Ramesh S. TSPO: an Evolutionarily Conserved Protein with Elusive Functions. Int J Mol Sci. 2018;19(6.
   Web of Science ®Google Scholar
• Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118(1):1–17.
   PubMed Web of Science ®Google Scholar
• Ory D, Planas A, Dresselaers T, et al. PET imaging of TSPO in a rat model of local neuroinflammation induced by intracerebral injection of lipopolysaccharide. Nucl Med Biol. 2015;42(10):753–761.
   PubMed Web of Science ®Google Scholar
• Beckers L, Ory D, Geric I, et al. Increased Expression of Translocator Protein (TSPO) Marks Pro-inflammatory Microglia but Does Not Predict Neurodegeneration. Mol Imaging Biol. 2018;20(1):94–102.
   PubMed Web of Science ®Google Scholar
• Best L, Ghadery C, Pavese N, et al. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease. Curr Neurol Neurosci Rep. 2019;19(5):24.
   PubMed Web of Science ®Google Scholar
• Turner MR, Cagnin A, Turkheimer FE, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15(3):601–609.
   PubMed Web of Science ®Google Scholar
• Nutma E, Stephenson JA, Gorter RP, et al. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain. 2019;142(11):3440–3455.
   PubMedGoogle Scholar
• Okello A, Edison P, Archer HA, et al. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology. 2009;72(1):56–62.
   PubMed Web of Science ®Google Scholar
• Hillmer AT, Holden D, Fowles K, et al. Microglial depletion and activation: a [(11)C]PBR28 PET study in nonhuman primates. EJNMMI Res. 2017;7(1):59.
   PubMedGoogle Scholar
• Hannestad J, Gallezot JD, Schafbauer T, et al. Endotoxin-induced systemic inflammation activates microglia: [(1)(1)C]PBR28 positron emission tomography in nonhuman primates. Neuroimage. 2012;63(1):232–239.
   PubMed Web of Science ®Google Scholar
• Chauveau F, Boutin H, Van Camp N, et al. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging. 2008;35(12):2304–2319.
   PubMed Web of Science ®Google Scholar
• Milenkovic VM, Bader S, Sudria-Lopez D, et al. Effects of genetic variants in the TSPO gene on protein structure and stability. PLoS One. 2018;13(4):e0195627.
   PubMed Web of Science ®Google Scholar
• Owen DR, Gunn RN, Rabiner EA, et al. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med. 2011;52(1):24–32.
   PubMed Web of Science ®Google Scholar
• Owen DR, Yeo AJ, Gunn RN, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32(1):1–5.
   PubMed Web of Science ®Google Scholar
• Janssen B, Vugts DJ, Windhorst AD, et al. PET Imaging of Microglial Activation-Beyond Targeting TSPO. Molecules. 2018;23(3):607. Doi: 10.3390/molecules23030607.
   Web of Science ®Google Scholar
• Savonenko AV, Melnikova T, Wang Y, et al. Cannabinoid CB2 Receptors in a Mouse Model of Abeta Amyloidosis: immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation. PLoS One. 2015;10(6):e0129618.
   PubMed Web of Science ®Google Scholar
• Ahmad R, Postnov A, Bormans G, et al. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2016;43(12):2219–2227.
   PubMed Web of Science ®Google Scholar
• Hoozemans JJ, Rozemuller AJ, Janssen I, et al. Cyclooxygenase expression in microglia and neurons in Alzheimer’s disease and control brain. Acta Neuropathol. 2001;101(1):2–8.
   PubMed Web of Science ®Google Scholar
• Choi SH, Langenbach R, Bosetti F. Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J. 2008;22(5):1491–1501.
   PubMed Web of Science ®Google Scholar
• Aid S, Bosetti F. Targeting cyclooxygenases-1 and −2 in neuroinflammation: therapeutic implications. Biochimie. 2011;93(1):46–51.
   PubMed Web of Science ®Google Scholar
• Shukuri M, Takashima-Hirano M, Tokuda K, et al. In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester. J Nucl Med. 2011;52(7):1094–1101.
   PubMed Web of Science ®Google Scholar
• Aid S, Silva AC, Candelario-Jalil E, et al. Cyclooxygenase-1 and −2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activity. J Cereb Blood Flow Metab. 2010;30(2):370–380.
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Biber K. The microglial ATP-gated ion channel P2X7 as a CNS drug target. Glia. 2016;64(10):1772–1787.
   PubMed Web of Science ®Google Scholar
• Skaper SD, Debetto P, Giusti P. The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J. 2010;24(2):337–345.
   PubMed Web of Science ®Google Scholar
• Ory D, Celen S, Gijsbers R, et al. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates. J Nucl Med. 2016;57(9):1436–1441.
   PubMed Web of Science ®Google Scholar
• Janssen B, Vugts DJ, Wilkinson SM, et al. Identification of the allosteric P2X7 receptor antagonist [(11)C]SMW139 as a PET tracer of microglial activation. Sci Rep. 2018;8(1):6580.
   PubMedGoogle Scholar
• Beaino W, Janssen B, Kooij G, et al. Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis. J Neuroinflammation. 2017;14(1):259.
   PubMedGoogle Scholar
• Kim E, Yang J, Beltran CD, et al. Role of spleen-derived monocytes/macrophages in acute ischemic brain injury. J Cereb Blood Flow Metab. 2014;34(8):1411–1419.
   PubMed Web of Science ®Google Scholar
• Prinz M, Priller J. Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J Neuroimmunol. 2010;224(1–2):80–84.
   PubMed Web of Science ®Google Scholar
• Morganti JM, Jopson TD, Liu S, et al. CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury. J Neurosci. 2015;35(2):748–760.
   PubMed Web of Science ®Google Scholar
• Gomez-Nicola D, Schetters ST, Perry VH. Differential role of CCR2 in the dynamics of microglia and perivascular macrophages during prion disease. Glia. 2014;62(7):1041–1052.
   PubMed Web of Science ®Google Scholar
• Peralta Ramos JM, Iribarren P, Bousset L, et al. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic alpha-Synuclein Administration. Front Immunol. 2019;10:80.
   PubMed Web of Science ®Google Scholar
• Baufeld C, O’Loughlin E, Calcagno N, et al. Differential contribution of microglia and monocytes in neurodegenerative diseases. J Neural Transm (Vienna). 2018;125(5):809–826.
   PubMed Web of Science ®Google Scholar
• Karlen SJ, Miller EB, Wang X, et al. Monocyte infiltration rather than microglia proliferation dominates the early immune response to rapid photoreceptor degeneration. J Neuroinflammation. 2018;15(1):344.
   PubMedGoogle Scholar
• Kim E, Cho S. Microglia and Monocyte-Derived Macrophages in Stroke. Neurotherapeutics. 2016;13(4):702–718.
   PubMed Web of Science ®Google Scholar
• Zarruk JG, Greenhalgh AD, David S. Microglia and macrophages differ in their inflammatory profile after permanent brain ischemia. Exp Neurol. 2018;301:120–132.
   PubMed Web of Science ®Google Scholar
• Russo MV, Latour LL, McGavern DB. Distinct myeloid cell subsets promote meningeal remodeling and vascular repair after mild traumatic brain injury. Nat Immunol. 2018;19(5):442–452.
   PubMed Web of Science ®Google Scholar
• Makinde HM, Cuda CM, Just TB, et al. Nonclassical Monocytes Mediate Secondary Injury, Neurocognitive Outcome, and Neutrophil Infiltration after Traumatic Brain Injury. J Immunol. 2017;199(10):3583–3591.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim N, Yenari MA. Mechanisms and potential therapeutic applications of microglial activation after brain injury. CNS Neurosci Ther. 2015;21(4):309–319.
   PubMed Web of Science ®Google Scholar
• Kumar A, Alvarez-Croda DM, Stoica BA, et al. Microglial/Macrophage Polarization Dynamics following Traumatic Brain Injury. J Neurotrauma. 2016;33(19):1732–1750.
   PubMed Web of Science ®Google Scholar
• Kumar A, Henry RJ, Stoica BA, et al. Neutral Sphingomyelinase Inhibition Alleviates LPS-Induced Microglia Activation and Neuroinflammation after Experimental Traumatic Brain Injury. J Pharmacol Exp Ther. 2019;368(3):338–352.
   PubMed Web of Science ®Google Scholar
• Adams RA, Bauer J, Flick MJ, et al. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med. 2007;204(3):571–582.
   PubMed Web of Science ®Google Scholar
• Gao T, Chen Z, Chen H, et al. Inhibition of HMGB1 mediates neuroprotection of traumatic brain injury by modulating the microglia/macrophage polarization. Biochem Biophys Res Commun. 2018;497(1):430–436.
   PubMed Web of Science ®Google Scholar
• Ghosh M, Xu Y, Pearse DD. Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines. J Neuroinflammation. 2016;13:9.
   PubMed Web of Science ®Google Scholar
• Gaire BP, Song MR, Choi JW. Sphingosine 1-phosphate receptor subtype 3 (S1P3) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization. J Neuroinflammation. 2018;15(1):284.
   PubMed Web of Science ®Google Scholar
• Zhou D, Ji L, Chen Y. TSPO Modulates IL-4-Induced Microglia/Macrophage M2 Polarization via PPAR-gamma Pathway. J Mol Neurosci. 2020;70(4):542–549.
   PubMed Web of Science ®Google Scholar
• Wen L, You W, Wang H, et al. Polarization of Microglia to the M2 Phenotype in a Peroxisome Proliferator-Activated Receptor Gamma-Dependent Manner Attenuates Axonal Injury Induced by Traumatic Brain Injury in Mice. J Neurotrauma. 2018;35(19):2330–2340.
   PubMed Web of Science ®Google Scholar
• Ji J, Xue TF, Guo XD, et al. Antagonizing peroxisome proliferator-activated receptor gamma facilitates M1-to-M2 shift of microglia by enhancing autophagy via the LKB1-AMPK signaling pathway. Aging Cell. 2018;17(4):e12774.
   PubMed Web of Science ®Google Scholar
• Zhao R, Ying M, Gu S, et al. Cysteinyl Leukotriene Receptor 2 is Involved in Inflammation and Neuronal Damage by Mediating Microglia M1/M2 Polarization through NF-kappaB Pathway. Neuroscience. 2019;422:99–118.
   PubMed Web of Science ®Google Scholar
• Lan X, Han X, Li Q, et al. Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia. Brain Behav Immun. 2017;61:326–339.
   PubMed Web of Science ®Google Scholar
• Miao H, Li R, Han C, et al. Minocycline promotes posthemorrhagic neurogenesis via M2 microglia polarization via upregulation of the TrkB/BDNF pathway in rats. J Neurophysiol. 2018;120(3):1307–1317.
   PubMed Web of Science ®Google Scholar
• Stowell RD, Sipe GO, Dawes RP, et al. Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex. Nat Neurosci. 2019;22(11):1782–1792.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Lu P, Wang K, et al. Dexmedetomidine Inhibits Neuroinflammation by Altering Microglial M1/M2 Polarization Through MAPK/ERK Pathway. Neurochem Res. 2020;45(2):345–353.
   PubMed Web of Science ®Google Scholar
• Gao J, Sun Z, Xiao Z, et al. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury. Br J Anaesth. 2019;123(6):827–838.
   PubMed Web of Science ®Google Scholar
• Sharma M, Arbabzada N, Flood PM. Mechanism underlying beta2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells. J Neuroimmunol. 2019;332:37–48.
   PubMed Web of Science ®Google Scholar
• Jackson ML, Srivastava AK, Cox CS Jr. Preclinical progenitor cell therapy in traumatic brain injury: a meta-analysis. J Surg Res. 2017;214:38–48.
   PubMed Web of Science ®Google Scholar
• Walker PA, Shah SK, Jimenez F, et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol. 2010;225(2):341–352.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang R, Yan K, et al. Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6. J Neuroinflammation. 2014;11:135.
   PubMed Web of Science ®Google Scholar
• Galindo LT, Filippo TR, Semedo P, et al. Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol Res Int. 2011;2011:564089.
   PubMedGoogle Scholar
• Walker PA, Bedi SS, Shah SK, et al. Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population. J Neuroinflammation. 2012;9:228.
   PubMed Web of Science ®Google Scholar
• Bedi SS, Walker PA, Shah SK, et al. Autologous bone marrow mononuclear cells therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. J Trauma Acute Care Surg. 2013;75(3):410–416.
   PubMed Web of Science ®Google Scholar
• Bedi SS, Hetz R, Thomas C, et al. Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. Stem Cells Transl Med. 2013;2(12):953–960.
   PubMed Web of Science ®Google Scholar
• Bedi SS, Aertker BM, Liao GP, et al. Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury. J Neuroinflammation. 2018;15(1):84.
   PubMedGoogle Scholar
• Kota DJ, Prabhakara KS, van Brummen AJ, et al. Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury. Stem Cells Transl Med. 2016;5(1):33–44.
   PubMed Web of Science ®Google Scholar
• Cox CS Jr., Baumgartner JE, Harting MT, et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery. 2011;68(3):588–600.
   PubMed Web of Science ®Google Scholar